BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15891566)

  • 1. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
    J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
    Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
    Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    Chamilos G; Kontoyiannis DP
    J Infect; 2005 Nov; 51(4):e225-8. PubMed ID: 16291275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
    Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
    Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
    Ramírez I; Moncada D
    Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
    Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
    Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
    Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
    Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
    Tsuji Y; Tokimatsu I; Sugita T; Nozaki M; Kobayashi D; Imai K; Kogawa K; Nonoyama S
    Pediatr Infect Dis J; 2008 Nov; 27(11):1035-7. PubMed ID: 18845986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
    Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
    Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Acremonium fungemia with voriconazole.
    Mattei D; Mordini N; Lo Nigro C; Gallamini A; Osenda M; Pugno F; Viscoli C
    Mycoses; 2003 Dec; 46(11-12):511-4. PubMed ID: 14641626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three cases of fungemia caused by Blastoschizomyces capitatus].
    Koç AN; Copur Çiçek A; Kaynar L; Sav H; Kasap Tekinşen FF; Atalay MA
    Mikrobiyol Bul; 2013 Oct; 47(4):734-41. PubMed ID: 24237444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
    Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
    Kudo K; Terui K; Sasaki S; Kamio T; Sato T; Ito E
    Bone Marrow Transplant; 2011 Feb; 46(2):310-1. PubMed ID: 20436525
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
    Cardenas-de la Garza JA; Ancer-Arellano J; Cuellar-Barboza A; Saenz-Ibarra B; Ocampo-Garza SS; Barboza-Quintana O; Gallardo-Rocha A; Vera-Cabrera L; Ocampo-Candiani J; Welsh O
    J Dermatol; 2019 Apr; 46(4):e128-e129. PubMed ID: 30295013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.